41 | GemcitabineFDA Link
01/2020
-
11/2002 |
23 | 130-nm albumin-bound paclitaxelIBA
01/2020
-
12/2011 |
20 | Proteins (Proteins, Gene)FDA Link
12/2022
-
04/2004 |
17 | DNA (Deoxyribonucleic Acid)IBA
10/2023
-
11/2006 |
11 | Phosphotransferases (Kinase)IBA
01/2017
-
03/2002 |
10 | Biomarkers (Surrogate Marker)IBA
10/2023
-
11/2005 |
10 | Small Interfering RNA (siRNA)IBA
02/2012
-
01/2008 |
6 | Messenger RNA (mRNA)IBA
11/2020
-
05/2002 |
6 | CollagenIBA
11/2020
-
07/2015 |
6 | Albumin-Bound PaclitaxelFDA Link
01/2020
-
11/2005 |
6 | HhAntag691IBA
01/2020
-
09/2009 |
6 | Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2017
-
07/2007 |
5 | Fluorouracil (Carac)FDA LinkGeneric
01/2019
-
10/2011 |
5 | Irinotecan (Camptosar)FDA LinkGeneric
01/2019
-
01/2013 |
5 | Hyaluronic Acid (Hyaluronan)IBA
10/2018
-
09/2011 |
5 | Antineoplastic Agents (Antineoplastics)IBA
01/2017
-
08/2002 |
4 | PlatinumIBA
01/2020
-
03/2008 |
4 | Cisplatin (Platino)FDA LinkGeneric
01/2020
-
10/2011 |
4 | Leucovorin (Folinic Acid)FDA Link
01/2019
-
02/2016 |
4 | Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
10/2018
-
11/2002 |
4 | OligonucleotidesIBA
01/2012
-
01/2008 |
3 | PEGPH20IBA
09/2023
-
01/2018 |
3 | NucleotidesIBA
01/2021
-
04/2004 |
3 | N- (3,4- difluoro- 2- (2- fluoro- 4- iodophenylamino)- 6- methoxyphenyl)- 1- (2,3- dihydroxypropyl)cyclopropane- 1- sulfonamideIBA
12/2020
-
05/2011 |
3 | Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
12/2020
-
05/2011 |
3 | AlbuminsIBA
01/2020
-
11/2005 |
3 | EnzymesIBA
01/2019
-
07/2002 |
3 | Doxorubicin (Adriamycin)FDA LinkGeneric
10/2018
-
10/2011 |
3 | Cdc25C phosphatase (211-221)IBA
09/2017
-
10/2011 |
3 | Paclitaxel (Taxol)FDA LinkGeneric
01/2016
-
11/2005 |
3 | Antisense OligonucleotidesIBA
06/2013
-
05/2004 |
3 | Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
05/2004
-
03/2003 |
2 | Histone Deacetylase InhibitorsIBA
12/2023
-
09/2023 |
2 | entinostat (MS 275)IBA
12/2023
-
09/2023 |
2 | copanlisibIBA
12/2020
-
01/2020 |
2 | ChromatinIBA
11/2020
-
10/2020 |
2 | triptolideIBA
11/2020
-
01/2019 |
2 | RNA (Ribonucleic Acid)IBA
01/2020
-
12/2011 |
2 | Drug CombinationsIBA
01/2020
-
04/2012 |
2 | Hydroxychloroquine (Plaquenil)FDA LinkGeneric
07/2019
-
08/2014 |
2 | CytokinesIBA
01/2019
-
10/2018 |
2 | ProdrugsIBA
01/2019
-
01/2017 |
2 | Hyaluronoglucosaminidase (Hyaluronidase)FDA Link
10/2018
-
09/2011 |
2 | Azacitidine (5 Azacytidine)FDA Link
01/2018
-
11/2011 |
2 | Polo-Like Kinase 1IBA
01/2018
-
05/2004 |
2 | Interleukin-6 (Interleukin 6)IBA
09/2017
-
04/2012 |
2 | Docetaxel (Taxotere)FDA Link
01/2016
-
02/2015 |
2 | Macrophage Colony-Stimulating FactorIBA
01/2016
-
07/2015 |
2 | Cysteine (L-Cysteine)FDA Link
07/2015
-
11/2005 |
2 | Temozolomide (Temodar)FDA LinkGeneric
02/2015
-
03/2004 |
2 | LigandsIBA
12/2014
-
09/2008 |
2 | Matrix Metalloproteinases (MMPs)IBA
10/2014
-
12/2011 |
2 | CaspasesIBA
06/2013
-
03/2002 |
2 | AndrogensIBA
01/2013
-
11/2011 |
2 | ErbB Receptors (EGF Receptor)IBA
04/2012
-
05/2011 |
2 | Lapatinib (GW572016)FDA Link
04/2012
-
04/2010 |
2 | Peptides (Polypeptides)IBA
02/2012
-
12/2011 |
2 | Aurora KinasesIBA
02/2012
-
03/2003 |
2 | AgarIBA
01/2012
-
11/2009 |
2 | ThioredoxinsIBA
03/2011
-
03/2008 |
2 | UA 62784IBA
07/2009
-
01/2009 |
2 | Complementary DNA (cDNA)IBA
01/2008
-
05/2002 |
2 | Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2008
-
11/2005 |
1 | Proliferating Cell Nuclear Antigen (PCNA)IBA
10/2023 |
1 | Advanced Glycation End ProductsIBA
10/2023 |
1 | RNA-Binding Proteins (RNA-Binding Protein)IBA
01/2023 |
1 | 5- (2'- naphthyl)- 7- 4- chlorophenyl- (2,3,6,8- tetrahydro)pyrrolo- (3,4- e)(1,4)- diazepine- 6- thioxo- 8- (1H,7H)oneIBA
01/2022 |
1 | Lactic Acid (Lactate)FDA LinkGeneric
11/2021 |
1 | IsotopesIBA
11/2021 |